COVID-19 & CancerFreeGuest Editorial SARS-CoV-2 and oncology drugsWhat do we mean when we talk about value? May 15, 2020Vol.46 No.20By Garth W. Strohbehn, Daniel A. Goldstein and Mark J. Ratain
COVID-19 & CancerFreeGuest Editorial With the COVID-19 pandemic, the cancer clinical trials—they are a-changing May 08, 2020Vol.46 No.19By Gregory Masters, Nicholas J. Petrelli and Kandie Dempsey
COVID-19 & CancerFreeGuest Editorial Embracing the increasing value of eHealth in patient-centered cancer care during the COVID-19 pandemic and beyond May 08, 2020Vol.46 No.19By Frank J. Penedo and Joshua Kronenfeld
COVID-19 & CancerFreeGuest Editorial COVID-19 and community cancer careA Panorama of a Catastrophe May 08, 2020Vol.46 No.19By Debra Patt and Michael Kolodziej
COVID-19 & CancerFreeGuest Editorial Cancer doesn’t wait—we are treating cancer patients now May 01, 2020Vol.46 No.18By Richard Bold and Timothy Donahue
COVID-19 & CancerFreeGuest Editorial The pandemic of COVID-19 and its effect on clinical trials in the communityHow do we move forward? May 01, 2020Vol.46 No.18By James N. Atkins
COVID-19 & CancerFreeGuest Editorial Under the onslaughts of COVID-19, Montefiore deployed a PPE strategy for patients—PREVENT/PROTECT/ENABLE May 01, 2020Vol.46 No.18By Balazs Halmos, Roman Perez-Soler, Stuart Packer, Mary G. LaRocca, Bruce Rapkin, Shalom Kalnicki and Joseph Sparano
COVID-19 & CancerFreeGuest Editorial COVID-Lung Cancer Consortium:An example of how the lung cancer community came together in a challenging time April 24, 2020Vol.46 No.17By Fred R. Hirsch, Paul A. Bunn Jr and John D. Minna
COVID-19 & CancerFreeGuest Editorial When disparities widen: COVID-19 in minority patients with cancer April 24, 2020Vol.46 No.17By Coral Olazagasti and Narjust Florez
COVID-19 & CancerFreeGuest Editorial Cancer care continues during COVID-19 pandemic—with new tools and old challenges April 17, 2020Vol.46 No.16By Ted Okon
